No significant differences were observed in metabolic parameters and markers of insulin resistance, endothelial function, oxidative stress, inflammation and liver transaminases (ALT and AST) with VSL#3® supplementation or placebo (Tables 2, 3). This evidence concerns the gene GPT and Insulin resistance.